OR-907

N/A

Report date: 2023/09/26 16:27:01

Base Information

Drug NameOR-907
Drug Alias NameOR-907ROR-907SOR-907
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrphan nuclear receptors antagonists
TargetsOrphan nuclear receptors
Therapy Area/IndicationsCushing SyndromeAdrenocortical Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrphagen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCushing SyndromeAdrenocortical Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A